Wells Fargo & Company Xtant Medical Holdings, Inc. Transaction History
Wells Fargo & Company
- $410 Billion
- Q1 2024
A detailed history of Wells Fargo & Company transactions in Xtant Medical Holdings, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 377 shares of XTNT stock, worth $278. This represents 0.0% of its overall portfolio holdings.
Number of Shares
377
Previous 370
1.89%
Holding current value
$278
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding XTNT
# of Institutions
34Shares Held
90.4MCall Options Held
0Put Options Held
0-
Orbimed Advisors LLC San Diego, CA73.1MShares$54.1 Million1.93% of portfolio
-
Altium Capital Management LP New York, NY7.65MShares$5.66 Million5.04% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT4MShares$2.96 Million0.3% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.55MShares$1.15 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny763KShares$564,8490.0% of portfolio
About Xtant Medical Holdings, Inc.
- Ticker XTNT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 108,226,000
- Market Cap $80.1M
- Description
- Xtant Medical Holdings, Inc. develops, manufactures, and markets regenerative medicine products and medical devices for orthopedic and neurological surgeons in the United States and internationally. Its biomaterial products include OsteoSponge that provides a natural scaffold for cellular in-growth and exposes bone-forming proteins to the healin...